ID   FHUi002-C
AC   CVCL_YT28
SY   MEN1-iPS-17; MEN1_17; 17_3052C2a3
DR   hPSCreg; FHUi002-C
DR   SKIP; SKIP005763
DR   Wikidata; Q93553597
RX   PubMed=32460232;
CC   From: Fujita Health University; Toyoake; Japan.
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YT26 ! FHUi002-A
OI   CVCL_YT27 ! FHUi002-B
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 5
//
RX   PubMed=32460232; DOI=10.1016/j.scr.2020.101846;
RA   Yoshida, Satoru
RA   Okura, Hanayuki
RA   Suga, Hidetaka
RA   Nishitomi, Tomohiko
RA   Sakurai, Akihiro
RA   Arima, Hiroshi
RA   Matsuyama, Akifumi
RT   "Generation of three induced pluripotent stem cell (iPSC) lines from a
RT   multiple endocrine neoplasia type 1 (MEN1) patient and three iPSC
RT   lines from an unaffected relative of the patient.";
RL   Stem Cell Res. 46:101846-101846(2020).
//